
Common Virus Improves Melanoma Treatment Response, Reduces Side Effects
A common virus carried by approximately half of adults worldwide may improve outcomes for melanoma patients receiving immunotherapy while also protecting against severe treatment-related side effects and limiting the spread, according to new research from …